SciVision Biotech Inc. (TPE:1786)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
67.50
+1.50 (2.27%)
Mar 10, 2026, 1:35 PM CST

SciVision Biotech Balance Sheet

Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2016
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 2020 - 2016
Cash & Equivalents
845.81706.02511.1587.02658.92
Upgrade
Short-Term Investments
79.999.9233.930.7136.92
Upgrade
Trading Asset Securities
128.65----
Upgrade
Cash & Short-Term Investments
1,054805.92745617.73695.84
Upgrade
Cash Growth
30.83%8.18%20.60%-11.23%68.36%
Upgrade
Accounts Receivable
242.14172.9495.1890.3478.37
Upgrade
Other Receivables
1.561.091.021.160.2
Upgrade
Receivables
243.7174.0296.2191.4978.56
Upgrade
Inventory
82.1572.2387.2595.8782.9
Upgrade
Prepaid Expenses
46.3947.9415.4818.6521.7
Upgrade
Other Current Assets
0.5966.359.9757.2946.24
Upgrade
Total Current Assets
1,4271,1661,004881.03925.24
Upgrade
Property, Plant & Equipment
1,2281,1761,1351,1841,246
Upgrade
Other Intangible Assets
1.41.682.152.673.38
Upgrade
Long-Term Deferred Tax Assets
7.145.0215.525.0431.33
Upgrade
Other Long-Term Assets
6.25.013.225.2356.48
Upgrade
Total Assets
2,6702,3542,1602,0982,262
Upgrade
Accounts Payable
16.413.276.7514.025.46
Upgrade
Accrued Expenses
-135.76102.5678.4-
Upgrade
Short-Term Debt
0.51----
Upgrade
Current Portion of Long-Term Debt
1.07134.79--303.37
Upgrade
Current Portion of Leases
10.184.731.221.21.24
Upgrade
Current Income Taxes Payable
2.3912.655.7713.97-
Upgrade
Current Unearned Revenue
1.552.687.020.71.71
Upgrade
Other Current Liabilities
142.5633.1921.6919.79113.86
Upgrade
Total Current Liabilities
174.65337.07144.99128.08425.64
Upgrade
Long-Term Debt
373.59-323.84386.69300
Upgrade
Long-Term Leases
100.8684.7222.8524.128.48
Upgrade
Pension & Post-Retirement Benefits
-8.1418.9225.4735.16
Upgrade
Long-Term Deferred Tax Liabilities
0.494.350.030.05-
Upgrade
Other Long-Term Liabilities
39.7623.1523.0322.9122.78
Upgrade
Total Liabilities
689.35457.43533.67587.31812.06
Upgrade
Common Stock
748.28717.92677.1661.9661.9
Upgrade
Additional Paid-In Capital
960.31844.08700.34648.26638.12
Upgrade
Retained Earnings
272.47335.25249.73201.61150.72
Upgrade
Comprehensive Income & Other
-0.82-0.2-0.66-0.84-0.86
Upgrade
Shareholders' Equity
1,9801,8971,6271,5111,450
Upgrade
Total Liabilities & Equity
2,6702,3542,1602,0982,262
Upgrade
Total Debt
486.2224.24347.91411.99633.09
Upgrade
Net Cash (Debt)
568.16581.69397.09205.7462.75
Upgrade
Net Cash Growth
-2.33%46.49%93.01%227.89%-31.96%
Upgrade
Net Cash Per Share
7.637.815.192.760.88
Upgrade
Filing Date Shares Outstanding
73.8371.7967.7166.1966.19
Upgrade
Total Common Shares Outstanding
73.8371.7967.7166.1966.19
Upgrade
Working Capital
1,253829.35858.92752.95499.6
Upgrade
Book Value Per Share
26.8226.4224.0222.8321.90
Upgrade
Tangible Book Value
1,9791,8951,6241,5081,446
Upgrade
Tangible Book Value Per Share
26.8026.4023.9922.7921.85
Upgrade
Land
-4.734.734.739.5
Upgrade
Buildings
-687.72686.59686.32688.54
Upgrade
Machinery
-926.47909.63896.45891.02
Upgrade
Construction In Progress
-20.573.54.620.77
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.